Brainstorm Cell Therapeutics (BCLI) Payables (2009 - 2026)
Brainstorm Cell Therapeutics' Payables came in at $8.75 million for Q2 2026, up 43.5% from $6.1 million a year earlier and up 1.2% from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Brainstorm Cell Therapeutics' Payables was $8.03 million, up 25.9% from FY2024.
- Payables carries a five-year compound annual growth rate of 8.2% (FY2020 to FY2025).
- Going back by year, Payables was $6.38 million in FY2024 (+28.8%), $4.95 million in FY2023 (-20.4%), $6.22 million in FY2022 (+68.2%) and $3.7 million in FY2021 (-31.7%).
- The Q2 2026 figure represents the highest quarterly Payables since Q4 2019.
- Year-over-year, Payables has increased for nine consecutive quarters, with growth averaging 31.2% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in Q3 2022 (growth of 133.5%), and the weakest in Q1 2024 (a decline of 39.9%).
- Business Quant data shows BCLI's Payables at $8.65 million (Q1 2026), $8.03 million (Q4 2025) and $6.52 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Brainstorm Cell Therapeutics | 10.92 Mn | 10.85 Mn | - | 8.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.75 Mn |
| Mar 31, 2026 | 8.65 Mn |
| Dec 31, 2025 | 8.03 Mn |
| Sep 30, 2025 | 6.52 Mn |
| Jun 30, 2025 | 6.10 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Dec 31, 2024 | 6.38 Mn |
| Sep 30, 2024 | 4.60 Mn |
| Jun 30, 2024 | 5.34 Mn |
| Mar 31, 2024 | 4.69 Mn |
| Dec 31, 2023 | 4.95 Mn |
| Sep 30, 2023 | 3.93 Mn |
| Jun 30, 2023 | 5.19 Mn |
| Mar 31, 2023 | 7.80 Mn |
| Dec 31, 2022 | 6.22 Mn |
| Sep 30, 2022 | 6.40 Mn |
| Jun 30, 2022 | 5.29 Mn |
| Mar 31, 2022 | 4.57 Mn |
| Dec 31, 2021 | 3.70 Mn |
| Sep 30, 2021 | 2.74 Mn |
API Access
Brainstorm Cell Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();